High up in the Alps?

Switzerland is targeting the start of the recreational cannabis trials program in the summer

The cannabis industry in Europe has grown significantly in recent years, and it looks like it’s about to take another big leap. A cannabis trials program is slated to begin this summer in Basel, Switzerland. There has been much speculation about the outcome of this study and its impact on the cannabis industry. Don’t worry, we have a complete package of everything there is to know about this dedicated recreational cannabis experimentation program. Read on as we shed more light and take a closer look at the gist of this testing program.

As mentioned, this particular program is a trial program, meaning it is only open to a select few and certain outcomes will be monitored. About 400 people were selected to participate in the experimental program. These individuals are granted access to purchase recreational cannabis products from designated dispensaries. The cannabis products used in this program are manufactured by Pure Production based in Switzerland.

Participants in this pilot program will be carefully monitored and regularly interviewed throughout the life of the program. The questions that participants must answer depend on their mental and physical health. The effects of the procured products on their normal physical routine are monitored. Participants are also rated based on their reactions to their ability to handle the psychoactive effects of the natural herb. Participants are evaluated throughout the program using prepared and validated questionnaires.

The selected participants of the program are all over 18 years old. Participants were all made aware of the terms and conditions associated with participating in the trial program. This includes ensuring that participants are appropriately punished if they are caught passing cannabis to other people. The trial program, which will last two and a half years, will involve researchers and local government agencies. Experts from the University of Basel and the University Psychiatric Clinics in Basel will also be involved in the study programme.

This experimental program had already received the green light from Parliament two years ago before it was implemented this year. The lower house of Switzerland’s Federal Assembly approved the bill after seeing the benefits a leisure market can bring to the nation. This is following in the footsteps of other European countries when it comes to legalizing medical and recreational cannabis. The trend has always been to set up a testing program first before moving on to full legalization and required regulations.

The Federal Office of Public Health in Switzerland stated that this trial program will help them understand how the sale of cannabis can be regulated. It also says it will help the government know of alternative forms of regulation that can be used as many people use the drug. A key aim of the exercise is also to see if buying the product legally has an impact on overall drug use. The state government believes that legal sourcing will reduce the illegal activities of black market vendors, who thrive in the nation.

The program will also help the country see if legalization will curb the effects of the already thriving black market. Switzerland has a ban on the cultivation, production and consumption of recreational cannabis, yet the product is widely used in the country. According to the Federal Office of Public Health, this is due to the successful activities of black markets. For this reason, this recreational cannabis trials program is being monitored by many in the country as it can be the answer to many questions.

Recreational cannabis has seen a gradual shift in the attitudes of various governments toward its legalization over the past year. Malta took the first step last year by becoming the first country in the EU to fully legalize recreational cannabis. Germany and Luxembourg are expected to follow these steps very soon, and if this program is successful, Switzerland might not be too far behind. For this reason, many recreational cannabis advocates in Europe are closely watching this trials program as it has tremendous potential for success.

The good side of this cannabis trials program in Switzerland is that it marks an important milestone for the cannabis industry in Europe. It is expected that other similar countries will follow suit and establish theirs as well. However, there is a certain level of concern about its effectiveness among various experts. The premise for these concerns hinges on the fact that the legalization of recreational activities in Europe is known to be slow. This is mainly because the success of these programs is usually sabotaged by various types of delays and bureaucracy.

The Dutch pilot program is an example of a cannabis trials program in Europe that has not reached its intended potential. The purpose of this program setup was to encourage limited cultivation and distribution of recreational cannabis. However, the program has faced several delays and delays since it was first announced. The program is now expected to start in the first months of 2023. The debacle of the Dutch pilot program leads many to believe that the summer cannabis study in Switzerland could suffer the same fate.

While there are many positive aspects to the success of this program, its failure will have enormous consequences. Its failure or delay could halt planned growth in recreational cannabis in Switzerland and Europe. Two and a half years is a long time in the cannabis industry, but that’s the time required to see what this trials program will bring. In the meantime, recreational cannabis advocates in Switzerland and Europe are hoping the trial program will be a success.

SWITZERLAND BECOMES LEGAL CANNABIS, READ MORE…

SWISS CANNABIS CLUBS START BUT WILL THEY LAST?

OR..

SUPERMARKETS IN SWITZERLAND SELLING WEED, TELL YOU WHAT?